옵션 체인은 다양한 행사가격과 만기일에 대한 Clarivate의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Clarivate에 대한 시장 심리를 평가합니다..

Clarivate (NYSE:CLVT) 주식, 옵션 체인

Clarivate

Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.

Equities

Broad U.S. Equity ETFs

Emerging Markets

Specialty ETFs

Emerging Market ETFs

Commodities

Politics

Global

Econ #s

Markets

Movers

ETFs

ALAB

BBWI

CLVT

SPDR Dow Jones Industrial Average ETF Trust

ISRA

SMCI

WOLF

이스라엘과 레바논은 이스라엘과 헤즈볼라 간의 1년 넘는 폭력적 충돌을 종식시키기 위한 휴전 협정의 틀에 합의했다고 한 고위 미국 관리가 월요일 아침 악시오스(Axios)에 전했다.

이스라엘·레바논, 휴전 협정 도달: 금 및 유가 하락, S&amp;P 500과 다우존스가 최고치 경신

Clarivate PLC

Kraft Heinz's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NYSE">KHC</a>) short percent of float has risen 11.14% since its last report. The company recently reported that it has 39.76 million shares sold short, which is 4.59% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.45 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Kraft Heinz Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741278641_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Kraft Heinz has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Kraft Heinz's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Kraft Heinz's peer group average for short interest as a percentage of float is 6.27%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Peering Into Kraft Heinz's Recent Short Interest

Bloom Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) short percent of float has risen 4.77% since its last report. The company recently reported that it has 45.53 million shares sold short, which is 31.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 10.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Bloom Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741278636_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Bloom Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Bloom Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Bloom Energy's peer group average for short interest as a percentage of float is 9.39%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on Bloom Energy?

Waters's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) short percent of float has fallen 18.89% since its last report. The company recently reported that it has 1.30 million shares sold short, which is 2.49% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.54 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Waters Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741278631_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Waters has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Waters's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Waters's peer group average for short interest as a percentage of float is 5.72%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Is the Market Bullish or Bearish on Waters?

Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) has outperformed the market over the past 10 years by 36.71% on an annualized basis producing an average annual return of 47.69%. Currently, Shopify has a market capitalization of $139.37 billion. 
Buying $100 In SHOP: If an investor had bought $100 of SHOP stock 10 years ago, it would be worth $4,948.97 today based on a price of $107.64 for SHOP at the time of writing.
<h3>Shopify's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741278626_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

SHOP

$100 Invested In Shopify 10 Years Ago Would Be Worth This Much Today

WIIM

Mistras Group shares are trading higher after the company reported better-than-expected Q4 financial results.

BWS Financial analyst Hamed Khorsand maintains Net Lease Office (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLOP#NYSE">NLOP</a>) with a Buy and maintains $46 price target.

Price Target

Analyst Ratings

NLOP

BWS Financial Maintains Buy on Net Lease Office, Maintains $46 Price Target

Zscaler Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) stock gained after the company reported better-than-expected <a target="_blank" href="https://www.benzinga.com/news/earnings/25/03/44153144/zscaler-shares-gain-after-q2-results-heres-why" rel="noreferrer noopener">second-quarter financial results</a> and issued third-quarter adjusted EPS guidance above estimates.
Zscaler reported quarterly earnings of&nbsp;78&nbsp;cents per share, which beat the analyst consensus estimate of&nbsp;69&nbsp;cents. Quarterly revenue was&nbsp;$647.9 million (up from $525 million a year ago),&nbsp;which beat the analyst consensus estimate of&nbsp;$635.56 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/03/44163030/chatgpt-parent-openais-specialized-ai-agents-could-cost-up-to-20-thousand-per-month-report" rel="noreferrer noopener">ChatGPT Parent OpenAI&#8217;s Specialized AI Agents Could Cost Up To $20 Thousand Per Month: report</a>
Zscaler expects third-quarter revenue of $665 million to $667 million, versus the $667.37 million estimate, and EPS of 75 cents to 76 cents per share, versus the 74 cent estimate.
Rosenblatt analyst Catharine Trebnick upgraded Zscaler from Neutral to Buy and raised the <a href="https://www.benzinga.com/quote/ZS/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $190 to $235</a>.
This upgrade is driven by Trebnick&#8217;s increased confidence in Zscaler&#8217;s ability to sustain strong growth based on key factors. The analyst marginally increased her revenue forecasts for fiscal 2025 and 2026, reflecting a belief in the company&#8217;s improved sales capacity, broader platform adoption and potential to capture legacy firewall refresh initiatives. Trebnick also observed improvements in Zscaler&#8217;s GTM motions and sales execution, which are contributing to stronger performance.
The rerating reflects demonstrable performance improvements. Zscaler&#8217;s latest results exceeded expectations, driven by improved billing growth and margin expansion.
Improved marketing (Zero Trust Everywhere) and sales productivity drive more significant deals and upsells.
Calculated billings of $743 million rose 18%, beating Street estimates by $23 million, fueled by 25% growth in unscheduled billings.
This performance prompted management to raise the fiscal 2025 billings outlook, a clear signal of the company&#8217;s continued confidence in the future.
Furthermore, new products, including ZDX, Zero Trust Cloud Workload and Zero Trust Branch, are gaining traction and expected to generate 25% of total revenue at year-end.
The combined improvements in GTM motion, sales productivity, and broader platform momentum led the analyst to note the company can sustain durable growth.
Trebnick projected third-quarter revenue of $666.6 million and EPS of $0.75.
Price Action: ZS stock is up 6.95% at $210.33 at last check Thursday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/03/44164458/jdcom-q4-earnings-double-digit-growth-retail-and-logistics-surge-hikes-dividend-to-100-per-ads" target="_blank" rel="noreferrer noopener">China&#8217;s JD.com Q4 Retail Revenue And Margin Growth Impress, Hikes Annual Dividend</a></li>
</ul>

Upgrades

Zscaler Gains Analyst Upgrade As Strong Billing Growth And Zero Trust Adoption Fuel Confidence

Telemedicine operator Teladoc Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) has entered a pharmacy integration agreement with Eli Lilly And Co's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) LillyDirect, a direct-to-consumer pharmacy partner, to streamline access to Zepbound (tirzepatide) for members of Teladoc's Comprehensive <a target="_blank" href="https://www.benzinga.com/topic/weight-loss" rel="noreferrer noopener">Weight Care Program</a>.
Last year, Eli Lilly&nbsp;announced a&nbsp;new&nbsp;website allowing patients to get a prescription for weight loss through a telehealth provider,&nbsp;<a target="_blank" href="https://www.benzinga.com/top-stories/24/05/38798101/pfizer-follows-eli-lillys-footsteps-to-sell-medicines-directly-to-patients" rel="noreferrer noopener">marking an industry first</a>.
The collaboration aims to provide affordable and safe options for individuals without insurance coverage for GLP-1 medications <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/g44164208/teladoc-health-adds-glp-1-self-pay-option-to-comprehensive-weight-care" rel="noreferrer noopener">used for obesity treatment</a>.
Under the agreement, eligible Teladoc Health members prescribed Zepbound by their provider will have the medication delivered directly to their homes via LillyDirect's digital healthcare platform.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42970274/teladoc-shares-surge-as-amazon-partnership-fuels-push-for-consumer-centric-healthcare" rel="noreferrer noopener">Teladoc Stock Gains As Amazon Partnership Fuels Push for Consumer-Centric Healthcare</a>
Teladoc's Comprehensive Weight Care and Primary360 teams will have full visibility into each stage of the fulfillment process, including dispensing, shipping, delivery, and refills.
Beyond medication access, Teladoc's Comprehensive Weight Care Program offers a multi-disciplinary approach to obesity management. Members receive support from licensed clinicians with specialized training in obesity medicine, registered dietitians, and health coaches.
Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>)&nbsp;recently introduced&nbsp;NovoCare Pharmacy, a direct-to-patient delivery service to improve access to Wegovy (semaglutide) for&nbsp;<a target="_blank" href="https://www.benzinga.com/25/03/44143391/novo-nordisk-boosts-wegovy-access-with-lower-pricing-and-home-delivery" rel="noreferrer noopener">cash-paying patients</a>.
In February, Teladoc reported fourth-quarter revenue&nbsp;of $640.5 million, down 3% year over year, almost in line with the <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43989576/teladoc-health-reports-full-year-and-fourth-quarter-2024-results" rel="noreferrer noopener">consensus estimates</a>.
Price Action: TDOC stock is up 8.02% at $9.75 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/03/44167381/target-hospitality-secures-five-year-lease-with-corecivic-for-dilley-facility-stock-gains" target="_blank" rel="noreferrer noopener">Target Hospitality Secures Five-Year Lease With CoreCivic For Dilley Facility, Stock Gains</a></li>
</ul>
Photo by Ciara Kimsey via Shutterstock

Large Cap

Health Care

Contracts

General

TDOC

Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss

Telsey Advisory Group analyst Dana Telsey maintains Burlington Stores (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BURL#NYSE">BURL</a>) with a Outperform and maintains $340 price target.

BURL

Telsey Advisory Group Maintains Outperform on Burlington Stores, Maintains $340 Price Target

SVCO

Silvaco Group shares are trading lower. The company reported Q4 financial results.

Telsey Advisory Group analyst Joseph Feldman maintains Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) with a Outperform and maintains $73 price target.

Telsey Advisory Group Maintains Outperform on Kroger, Maintains $73 Price Target

CTOS

Custom Truck One Source shares are trading higher after Oppenheimer raised its price target on the stock from $5 to $6 and maintained its Outperform rating.

Macquarie analyst Paul Golding maintains United Parks &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRKS#NYSE">PRKS</a>) with a Outperform and lowers the price target from $70 to $65.

PRKS

Macquarie Maintains Outperform on United Parks & Resorts, Lowers Price Target to $65

Trading Halt: Halt status updated at 11:25:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Teladoc Health shares are trading higher after the company announced a pharmacy integration agreement with Gifthealth for a GLP-1 self-pay option.

Macquarie analyst Paul Golding maintains Norwegian Cruise Line (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NCLH#NYSE">NCLH</a>) with a Outperform and raises the price target from $30 to $31.

NCLH

Macquarie Maintains Outperform on Norwegian Cruise Line, Raises Price Target to $31

TRML

Tourmaline Bio shares are trading higher after Wedbush initiated coverage on the stock with an Outperform rating and announced a price target of $42.

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health shares are trading lower following reports suggesting a federal judge ruled in favor of the FDA in the tirzepatide compounding case.

Macquarie analyst Paul Golding maintains Live Nation Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>) with a Outperform and raises the price target from $146 to $165.

Macquarie Maintains Outperform on Live Nation Entertainment, Raises Price Target to $165

HIPO

Hippo Holdings shares are trading higher following better-than-expected Q4 financial results.

Press Releases

BioWorld by Clarivate Releases Comprehensive 2024 Year in Review

Clarivate to Report Fourth Quarter and Full Year 2024 Results on February 19, 2025

The British Library Selects Clarivate to Provide Library Services and Discovery Platforms

Clarivate identifies top 50 universities powering global innovation

Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market

Clarivate Selected by National and University Library in Zagreb, Croatia to Create a Unified National Library Platform

Clarivate Recognized for Excellence in Trademark Business in the WTR 1000 2025

Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia

Earnings

Clarivate Reports Fourth Quarter and Full Year 2024 Results

Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America

Comments

Clarivate

Clarivate (CLVT) 옵션

Clarivate (NYSE:CLVT) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌